Abeona Therapeutics (ABEO) Competitors $5.98 +0.19 (+3.28%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ABEO vs. ACRS, QURE, VYGR, RGNX, LUMO, COGT, BCAX, ZYME, BCYC, and UPBShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Aclaris Therapeutics (ACRS), uniQure (QURE), Voyager Therapeutics (VYGR), REGENXBIO (RGNX), Lumos Pharma (LUMO), Cogent Biosciences (COGT), Bicara Therapeutics (BCAX), Zymeworks (ZYME), Bicycle Therapeutics (BCYC), and Upstream Bio (UPB). These companies are all part of the "medical" sector. Abeona Therapeutics vs. Aclaris Therapeutics uniQure Voyager Therapeutics REGENXBIO Lumos Pharma Cogent Biosciences Bicara Therapeutics Zymeworks Bicycle Therapeutics Upstream Bio Abeona Therapeutics (NASDAQ:ABEO) and Aclaris Therapeutics (NASDAQ:ACRS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation. Does the media refer more to ABEO or ACRS? In the previous week, Aclaris Therapeutics had 41 more articles in the media than Abeona Therapeutics. MarketBeat recorded 43 mentions for Aclaris Therapeutics and 2 mentions for Abeona Therapeutics. Aclaris Therapeutics' average media sentiment score of 0.58 beat Abeona Therapeutics' score of -0.60 indicating that Aclaris Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abeona Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Aclaris Therapeutics 6 Very Positive mention(s) 5 Positive mention(s) 19 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ABEO or ACRS? Abeona Therapeutics received 138 more outperform votes than Aclaris Therapeutics when rated by MarketBeat users. Likewise, 70.12% of users gave Abeona Therapeutics an outperform vote while only 66.61% of users gave Aclaris Therapeutics an outperform vote. CompanyUnderperformOutperformAbeona TherapeuticsOutperform Votes52170.12% Underperform Votes22229.88% Aclaris TherapeuticsOutperform Votes38366.61% Underperform Votes19233.39% Do analysts rate ABEO or ACRS? Abeona Therapeutics presently has a consensus price target of $18.00, suggesting a potential upside of 201.00%. Aclaris Therapeutics has a consensus price target of $8.80, suggesting a potential upside of 131.58%. Given Abeona Therapeutics' higher probable upside, analysts plainly believe Abeona Therapeutics is more favorable than Aclaris Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aclaris Therapeutics 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in ABEO or ACRS? 80.6% of Abeona Therapeutics shares are owned by institutional investors. Comparatively, 98.3% of Aclaris Therapeutics shares are owned by institutional investors. 5.4% of Abeona Therapeutics shares are owned by insiders. Comparatively, 6.4% of Aclaris Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, ABEO or ACRS? Abeona Therapeutics has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500. Comparatively, Aclaris Therapeutics has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500. Is ABEO or ACRS more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Aclaris Therapeutics' net margin of -136.65%. Aclaris Therapeutics' return on equity of -40.26% beat Abeona Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Abeona TherapeuticsN/A -203.27% -64.56% Aclaris Therapeutics -136.65%-40.26%-31.71% Which has preferable valuation and earnings, ABEO or ACRS? Abeona Therapeutics has higher earnings, but lower revenue than Aclaris Therapeutics. Aclaris Therapeutics is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbeona Therapeutics$3.50M74.27-$54.19M-$2.69-2.22Aclaris Therapeutics$27.08M10.02-$88.48M-$0.52-7.31 SummaryAclaris Therapeutics beats Abeona Therapeutics on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$259.96M$6.99B$5.38B$8.84BDividend YieldN/A8.15%5.13%4.09%P/E Ratio-2.2211.10105.1417.83Price / Sales74.27362.031,233.15158.41Price / CashN/A52.5940.4136.29Price / Book5.7010.377.096.50Net Income-$54.19M$153.60M$119.65M$226.22M7 Day Performance2.05%4.60%2.25%4.03%1 Month Performance-4.32%-6.29%-2.33%4.92%1 Year Performance44.10%33.41%33.98%29.30% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.5675 of 5 stars$5.98+3.3%$18.00+201.0%+44.1%$259.96M$3.50M-2.22N/AAnalyst UpgradeACRSAclaris Therapeutics3.8433 of 5 stars$3.80-12.0%$8.80+131.6%+366.7%$271.44M$27.08M-7.3186Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeQUREuniQure2.9387 of 5 stars$5.78-1.0%$17.00+194.1%-14.9%$281.74M$28.59M-1.18500News CoverageVYGRVoyager Therapeutics4.6684 of 5 stars$5.66+4.2%$17.00+200.6%-17.8%$308.91M$163.78M7.97100RGNXREGENXBIO4.4572 of 5 stars$9.59+4.5%$35.27+267.8%-49.9%$475.14M$84.33M-1.91344Analyst ForecastAnalyst RevisionNews CoverageLUMOLumos Pharma2.621 of 5 stars$4.31-0.5%$8.63+100.1%+39.9%$37.28M$2.05M-1.0030High Trading VolumeCOGTCogent Biosciences2.8646 of 5 stars$9.13+1.7%$14.83+62.5%+40.0%$1.01BN/A-3.6880BCAXBicara Therapeutics3.1952 of 5 stars$18.09+1.8%$43.33+139.5%N/A$984.46MN/A0.0032ZYMEZymeworks3.3184 of 5 stars$14.29+4.5%$19.00+33.0%+71.3%$984.27M$62.20M-9.55290Analyst ForecastNews CoverageBCYCBicycle Therapeutics2.8041 of 5 stars$20.54+1.4%$40.13+95.4%+48.6%$976.76M$36.90M-6.24240Analyst RevisionUPBUpstream Bio1.9091 of 5 stars$18.19+2.2%$56.50+210.6%N/A$974.98MN/A0.0038Quiet Period Expiration Related Companies and Tools Related Companies Aclaris Therapeutics Alternatives uniQure Alternatives Voyager Therapeutics Alternatives REGENXBIO Alternatives Lumos Pharma Alternatives Cogent Biosciences Alternatives Bicara Therapeutics Alternatives Zymeworks Alternatives Bicycle Therapeutics Alternatives Upstream Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ABEO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
